Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The treatment successfully lowered testosterone levels and reduced symptoms.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone treatment may affect heart response to stress in transgender men.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Testosterone therapy is safe and effective for women but is limited by cost and lack of awareness.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Balancing hormones can help women feel youthful and healthy.